Tadao Akizawa

25PUBLICATIONS
39CO-AUTHORS
PharmacogenomicsCatalysis and mechanisms of reactionsTraditional Chinese medicine and treatmentsCardiology (incl. cardiovascular diseases)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jul 06, 2026
Safety of Daprodustat for the Treatment of Chronic Kidney Disease Anemia: Final Analysis of a Multicenter Postmarketing Surveillance Study in Japan.

|Feb 22, 2026
Upacicalcet: A Novel Intravenous Calcimimetic Agent for Patients Undergoing Hemodialysis With Secondary Hyperparathyroidism.

Fumihiko Koiwa, Daisuke Honda, Seigo Akari

|Jan 20, 2025
Tenapanor: A novel therapeutic agent for dialysis patients with hyperphosphatemia.

Tadao Akizawa, Natsuki Urano, Kazuaki Ikejiri

|Aug 05, 2024
Physician and Patient Preferences for Treatment of Anemia Associated with Chronic Kidney Disease in Japan: A Survey Including Best-Worst Scaling.

Sari Mishina, Yuichiro Ito, Takumi Lee

|Mar 12, 2024
Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial.

Masanori Kato, Hidetoshi Ito, Akane Yamakawa

|Feb 25, 2024
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia.

Kyoko Ito, Tadao Akizawa, Kojo Arita

Pageof 5

Frequent Collaborators

6 joint publications

Masafumi Fukagawa

3 joint publications

Hiroaki Ogata

2 joint publications

Hiroyasu Yamamoto

2 joint publications

Takashi Shigematsu